MeSH tree: D03.383.725.791.298
A multi-institutional study made up of 26 researchers led by the University of Melbourne has discovered that iron-reducing deferiprone accelerates cognitive decline in patients with early Alzheimer's disease. This unexpected ...
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers. The preclinical study, ...
Jul 29, 2024
0
30
New USC research shows that iron serves as a gas pedal driving certain immune cells that cause inflammation in the lungs during an allergic asthma attack—and blocking or limiting iron may reduce the severity of symptoms.
May 8, 2024
0
57
Fibrosis is associated with various chronic and life-threatening conditions, including pulmonary fibrosis, liver cirrhosis, kidney disease, and cardiovascular diseases, among others. These conditions collectively contribute ...
Dec 14, 2023
0
63
Researchers from Nagoya University Graduate School of Medicine have identified the role of iron in ocular toxoplasmosis (OT), a form of toxoplasmosis that causes blindness. They found reduced iron concentration in the clear ...
Nov 15, 2023
0
36
For patients newly diagnosed with Parkinson disease, deferiprone is associated with worse scores in measures of parkinsonism, according to a study published in the Dec. 1 issue of the New England Journal of Medicine.
Dec 1, 2022
0
44
